# Impact of Fecal Microbiota Transplantation in Ulcerative Colitis

> **NCT03483246** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 150 (estimated)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** Fecal Microbiota Transplantation (FMT)
- **DRUG:** Sham-transplantation Placebo

## Key facts

- **NCT ID:** NCT03483246
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-09-17
- **Primary completion:** 2025-09-16
- **Final completion:** 2027-03-27
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-01-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03483246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03483246, "Impact of Fecal Microbiota Transplantation in Ulcerative Colitis". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03483246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*